Pharmacokinetics and Pharmacodynamics of Biotech Drugs (PDF)
Principles and Case Studies in Drug Development
(Sprache: Englisch)
This first ever coverage of the pharmacokinetic and pharmacodynamic characteristics of biopharmaceuticals meets the need for a comprehensive book in this field. It spans all topics from lead identification right up to final-stage clinical trials.
Following...
Following...
sofort als Download lieferbar
eBook (pdf)
165.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „Pharmacokinetics and Pharmacodynamics of Biotech Drugs (PDF)“
This first ever coverage of the pharmacokinetic and pharmacodynamic characteristics of biopharmaceuticals meets the need for a comprehensive book in this field. It spans all topics from lead identification right up to final-stage clinical trials.
Following an introduction to the role of PK and PD in the development of biotech drugs, the book goes on to cover the basics, including the pharmacokinetics of peptides, monoclonal antibodies, antisense oligonucleotides, as well as viral and non-viral gene delivery vectors. The second section discusses such challenges and opportunities as pulmonary delivery of proteins and peptides, and the delivery of oligonucleotides. The final section considers the integration of PK and PD concepts into the biotech drug development plan, taking as case studies the preclinical and clinical drug development of tasidotin, as well as the examples of cetuximab and pegfilgrastim.
The result is vital reading for all pharmaceutical researchers.
Following an introduction to the role of PK and PD in the development of biotech drugs, the book goes on to cover the basics, including the pharmacokinetics of peptides, monoclonal antibodies, antisense oligonucleotides, as well as viral and non-viral gene delivery vectors. The second section discusses such challenges and opportunities as pulmonary delivery of proteins and peptides, and the delivery of oligonucleotides. The final section considers the integration of PK and PD concepts into the biotech drug development plan, taking as case studies the preclinical and clinical drug development of tasidotin, as well as the examples of cetuximab and pegfilgrastim.
The result is vital reading for all pharmaceutical researchers.
Inhaltsverzeichnis zu „Pharmacokinetics and Pharmacodynamics of Biotech Drugs (PDF)“
The Role of Pharmacokinetics and Pharmacodynamics in the Development of Biotech Drugs Pharmacokinetics of Peptides and Proteins Pharmacokinetics of Monoclonal Antibodies Pharmacokinetics and Pharmacodynamics of Antisense Oligonucleotides Pharmacokinetics of Viral and Non-Viral Gene Delivery Vectors Bioanalytical Methods used for Pharmacokinetic Evaluations of Biotech Macromolecule Drugs: Issues, Assay Approaches, and Limitations Limitations of Noncompartmental Pharmacokinetic Analysis of Biotech Drugs Bioequivalence of Biologics Biopharmaceutical Challenges in Pulmonary Delivery of Proteins and Peptides Biopharmaceutical Challenges: Delivery of Oligonucleotides Custom-Tailored Pharmacokinetics and Pharmacodynamics via Chemical Modifications of Biotech Drugs Exposure-Response Relationships for Therapeutic Biologic Products Preclinical and Clinical Drug Development of Tasidotin, a Depsi-Pentapeptide Oncolytic Agent Clinical Drug Development of Cetuximab, a Monoclonal Antibody Integration of Pharmacokinetics and Pharmacodynamics into the Drug Development of Pegfilgrastim, a Pegylated Protein
Autoren-Porträt
Bernd Meibohm is an Associate Professor of Pharmaceutical Sciences at the College of Pharmacy of the University of Tennessee Health Science Center, Memphis. He obtained his PhD from the University Carolo-Wilhelmina in Braunschweig, Germany, and underwent postdoctoral training in clinical pharmacology at the University of Florida, Gainesville. His research is focused on pharmacokinetics (PK), pharmacodynamics (PD), and pharmacogenetics (PG) with special emphasis on PK/PD/PG correlations. Professor Meibohm is a Fellow of the American College of Clinical Pharmacology (ACCP) and has received numerous awards, including the 'Young Investigator Award in PK, PD and Drug Metabolism' from the American Association of Pharmaceutical Scientists (AAPS) in 2000. He is currently serving as Section Editor for PK and PD for the 'Journal of Clinical Pharmacology' and on the Editorial Boards of the 'Journal of Pediatric Pharmacology and Therapeutics' and 'Die Pharmazie'.
Bibliographische Angaben
- 2006, 1. Auflage, 404 Seiten, Englisch
- Herausgegeben: Bernd Meibohm
- Verlag: Wiley-VCH GmbH
- ISBN-10: 3527609520
- ISBN-13: 9783527609529
- Erscheinungsdatum: 13.12.2006
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: PDF
- Größe: 6.67 MB
- Mit Kopierschutz
Sprache:
Englisch
Kopierschutz
Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.
Kommentar zu "Pharmacokinetics and Pharmacodynamics of Biotech Drugs"
Schreiben Sie einen Kommentar zu "Pharmacokinetics and Pharmacodynamics of Biotech Drugs".
Kommentar verfassen